This summary was created by AI, based on 1 opinions in the last 12 months.
IDEXX Laboratories, recognized by its stock symbol IDXX-Q, has received mixed feedback from various experts. One prominent review highlights a significant concern over the company's inconsistency in performance, suggesting that investors may face unpredictability with the stock. This inconsistency could indicate underlying issues that might detract from long-term investor confidence. Despite its standing in the market, experts emphasize the need for caution due to the lack of reliability in performance metrics. As more insights emerge, potential investors should consider these factors carefully when evaluating IDEXX Laboratories for their portfolios.
Makes diagnostic equipment for veterinarians. It has sold off hard, because pet plays are seen as Covid stocks, but has been recovering (reported a beat in early August), but shares have been cold since that report.
IDEXX Laboratories is a American stock, trading under the symbol IDXX-Q on the NASDAQ (IDXX). It is usually referred to as NASDAQ:IDXX or IDXX-Q
In the last year, 1 stock analyst published opinions about IDXX-Q. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for IDEXX Laboratories.
IDEXX Laboratories was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for IDEXX Laboratories.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered IDEXX Laboratories In the last year. It is a trending stock that is worth watching.
On 2025-03-14, IDEXX Laboratories (IDXX-Q) stock closed at a price of $415.3.
They're too inconsistent.